ARTICLE | Clinical News
Spiriva HandiHaler tiotropium bromide regulatory update
January 18, 2010 8:00 AM UTC
FDA said current data do not support an increased risk of stroke, heart attack or death in patients using Spiriva HandiHaler tiotropium bromide from Boehringer and Pfizer to treat chronic obstructive ...